Literature DB >> 25406456

Changing indications for a total pancreatectomy: perspectives over a quarter of a century.

Max Almond1, Keith J Roberts, James Hodson, Robert Sutcliffe, Ravi Marudanayagam, John Isaac, Paolo Muiesan, Darius Mirza.   

Abstract

INTRODUCTION: The indications for a total pancreatectomy (TP), its peri-operative management, provision of pancreatic surgical services and medical treatment of the inherent exo- and endocrine deficient states have all changed considerably over recent decades. The effects of these upon the incidence, indications for and outcomes of TP are unclear. Patients undergoing TP at a single institution over a quarter of a century were reviewed to try to address these issues.
METHODS: Data on patients who underwent elective (el-) and emergency TP (em-TP) between 1987 and 2013 were reviewed. Patient demographics, indications, intra-operative details, peri-operative management and long-term outcomes were analysed. Absolute numbers of TP were reported relative to partial pancreatectomy rates.
RESULTS: In total, 136 patients underwent TP [98 (72.1%) el-TP; 38 (27.9%) em-TP]. There was a significant change in indication for el-TP with it increasingly performed for (an intraductal papillary mucinous neoplasm (IPMN) and renal cell metastases whereas there was a decrease in the number of el-TP performed for chronic pancreatitis (P = 0.025). The relative rates of el-TP, however, did not change significantly across the study period (P = 0.225). The median length of stay after el-TP decreased from 19 days pre-1997 to 12 days post-1997 (P = 0.009). The relative use of em-TP declined by 0.28 percentage points per year [P = 0.018; 95% confidence interval (CI): 0.04-0.41].
CONCLUSIONS: The indications for el-TP have changed; it is being performed more frequently although the proportion relative to other pancreatic resections has not changed. A decrease in the rate of em-TP is likely to reflect improved peri-operative management of a pancreatic fistula and its complications after a pancreaticoduodenectomy.
© 2014 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2014        PMID: 25406456      PMCID: PMC4402052          DOI: 10.1111/hpb.12365

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  17 in total

1.  Familial pancreatic cancer.

Authors:  D K Bartsch
Journal:  Br J Surg       Date:  2003-04       Impact factor: 6.939

Review 2.  Total pancreatectomy: indications, operative technique, and postoperative sequelae.

Authors:  David G Heidt; Charles Burant; Diane M Simeone
Journal:  J Gastrointest Surg       Date:  2007-02       Impact factor: 3.452

3.  Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?

Authors:  Brian J Billings; John D Christein; William S Harmsen; Jeffrey R Harrington; Suresh T Chari; Florencia G Que; Michael B Farnell; David M Nagorney; Michael G Sarr
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

4.  Pancreatic fistula after pancreaticoduodenectomy: the conservative treatment of choice.

Authors:  Luciana B P Haddad; Olivier Scatton; Bruto Randone; Wellington Andraus; Pierre-Philippe Massault; Bertrand Dousset; Olivier Soubrane
Journal:  HPB (Oxford)       Date:  2009-05       Impact factor: 3.647

5.  Impact of total pancreatectomy: short- and long-term assessment.

Authors:  Louise Barbier; Wisam Jamal; Safi Dokmak; Béatrice Aussilhou; Olivier Corcos; Philippe Ruszniewski; Jacques Belghiti; Alain Sauvanet
Journal:  HPB (Oxford)       Date:  2013-01-29       Impact factor: 3.647

6.  Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma.

Authors:  C Max Schmidt; Jeffrey Glant; Jordan M Winter; Jason Kennard; Jennifer Dixon; Qianqian Zhao; Thomas J Howard; James A Madura; Atilla Nakeeb; Henry A Pitt; John L Cameron; Charles J Yeo; Keith D Lillemoe
Journal:  Surgery       Date:  2007-10       Impact factor: 3.982

7.  Patient outcomes after total pancreatectomy: a single centre contemporary experience.

Authors:  John A Stauffer; Justin H Nguyen; Michael G Heckman; Manpreet S Grewal; Marjorie Dougherty; Kanwar R S Gill; Laith H Jamil; Daniela Scimeca; Massimo Raimondo; C Daniel Smith; J Kirk Martin; Horacio J Asbun
Journal:  HPB (Oxford)       Date:  2009-09       Impact factor: 3.647

8.  Total pancreatectomy: a national study.

Authors:  Melissa M Murphy; William J Knaus; Sing Chau Ng; Joshua S Hill; James T McPhee; Shimul A Shah; Jennifer F Tseng
Journal:  HPB (Oxford)       Date:  2009-09       Impact factor: 3.647

9.  Diabetic control after total pancreatectomy.

Authors:  P Jethwa; M Sodergren; A Lala; J Webber; J A C Buckels; S R Bramhall; D F Mirza
Journal:  Dig Liver Dis       Date:  2006-03-09       Impact factor: 4.088

10.  Is there still a role for total pancreatectomy?

Authors:  Michael W Müller; Helmut Friess; Jörg Kleeff; Rolf Dahmen; Markus Wagner; Ulf Hinz; Daniela Breisch-Girbig; Güralp O Ceyhan; Markus W Büchler
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

View more
  11 in total

1.  Is total pancreatectomy as feasible, safe, efficacious, and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study.

Authors:  Riccardo Casadei; Claudio Ricci; Giovanni Taffurelli; Anna Guariniello; Anthony Di Gioia; Mariacristina Di Marco; Nico Pagano; Carla Serra; Lucia Calculli; Donatella Santini; Francesco Minni
Journal:  J Gastrointest Surg       Date:  2016-07-14       Impact factor: 3.452

Review 2.  Minimally invasive surgical approach to pancreatic malignancies.

Authors:  Lapo Bencini; Mario Annecchiarico; Marco Farsi; Ilenia Bartolini; Vita Mirasolo; Francesco Guerra; Andrea Coratti
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

3.  A Contemporary Evaluation of the Cause of Death and Long-Term Quality of Life After Total Pancreatectomy.

Authors:  Wenchuan Wu; Rebecca Dodson; Martin A Makary; Matthew J Weiss; Kenzo Hirose; John L Cameron; Nita Ahuja; Timothy M Pawlik; Christopher L Wolfgang; Jin He
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

Review 4.  Surgical Management of Postoperative Grade C Pancreatic Fistula following Pancreatoduodenectomy.

Authors:  Orlando Jorge Martins Torres; José Maria Assunção Moraes-Junior; Eduardo de Souza Martins Fernandes; Thilo Hackert
Journal:  Visc Med       Date:  2022-03-02

5.  Is primary total pancreatectomy in patients with high-risk pancreatic remnant justified and preferable to pancreaticoduodenectomy? -a matched-pairs analysis of 200 patients.

Authors:  Andreas Minh Luu; Bella Olchanetski; Torsten Herzog; Andrea Tannapfel; Waldemar Uhl; Orlin Belyaev
Journal:  Gland Surg       Date:  2021-02

6.  Total pancreatectomy: Short- and long-term outcomes at a high-volume pancreas center.

Authors:  Hazem M Zakaria; John A Stauffer; Massimo Raimondo; Timothy A Woodward; Michael B Wallace; Horacio J Asbun
Journal:  World J Gastrointest Surg       Date:  2016-09-27

Review 7.  Are there still indications for total pancreatectomy?

Authors:  Marco Del Chiaro; Elena Rangelova; Ralf Segersvärd; Urban Arnelo
Journal:  Updates Surg       Date:  2016-09-07

8.  Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy.

Authors:  Hao-Jun Shi; Chen Jin; De-Liang Fu
Journal:  World J Gastroenterol       Date:  2017-01-14       Impact factor: 5.742

9.  Two forms of one complication: Late erosive and nonerosive postpancreatectomy hemorrhage following laparoscopic pancreaticoduodenectomy.

Authors:  Feng Feng; Xuehui Cao; Xueqing Liu; Jianzhang Qin; Zhongqiang Xing; Jiayue Duan; Chen Liu; Jianhua Liu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

10.  Systematic review of functional outcome and quality of life after total pancreatectomy.

Authors:  L Scholten; T F Stoop; M Del Chiaro; O R Busch; C van Eijck; I Q Molenaar; J H de Vries; M G Besselink
Journal:  Br J Surg       Date:  2019-09-10       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.